Mor is proud to present a portfolio of innovative projects that have attracted investors from around the world, leading to the establishment of numerous companies. In most cases, our company holds patent rights of the innovations, and contributed to their success. Recent examples include:
MediWound Ltd. – innovative debriding agent.
CanFite Biopharma Ltd – novel treatments for auto-immune diseases and cancer.
Modigene - longer-lasting, proprietary versions of already approved therapeutic proteins
Minoguard - combination treatment in the area of psychotic diseases
MGVS Ltd – treatment products for heart and blood vessel disorders.
Rafael Medical – innovative transcatheter intravascular devices.
PROTEA Biosciences Inc. – improves protein sample preparation for downstream analysis.
Biogal – pharmaceutical compound using erythropoietin for the treatment of cancer and multiple myeloma.
EndoCross – novel catheter-based system for treating vascular occlusions.
Intumed – Self-guided and fully automatic intubation system.
CureTech Ltd – immunity modulators for cancer treatment.
Medigene - antibody against ovarian cancer.
OBEcure – drug therapies to treat obesity.